Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer

Two decades of studies in multiple model organisms have established the Hippo pathway as a key regulator of organ size and tissue homeostasis. By inhibiting YAP and TAZ transcription co-activators, the Hippo pathway regulates cell proliferation, apoptosis, and stemness in response to a wide range of...

Full description

Saved in:
Bibliographic Details
Published inCell Vol. 163; no. 4; pp. 811 - 828
Main Authors Yu, Fa-Xing, Zhao, Bin, Guan, Kun-Liang
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 05.11.2015
Subjects
Online AccessGet full text
ISSN0092-8674
1097-4172
1097-4172
DOI10.1016/j.cell.2015.10.044

Cover

More Information
Summary:Two decades of studies in multiple model organisms have established the Hippo pathway as a key regulator of organ size and tissue homeostasis. By inhibiting YAP and TAZ transcription co-activators, the Hippo pathway regulates cell proliferation, apoptosis, and stemness in response to a wide range of extracellular and intracellular signals, including cell-cell contact, cell polarity, mechanical cues, ligands of G-protein-coupled receptors, and cellular energy status. Dysregulation of the Hippo pathway exerts a significant impact on cancer development. Further investigation of the functions and regulatory mechanisms of this pathway will help uncovering the mystery of organ size control and identify new targets for cancer treatment. In response to a variety of cellular signals, the Hippo pathway plays key roles in regulating tissue homeostasis, stemness, and cancer development.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:0092-8674
1097-4172
1097-4172
DOI:10.1016/j.cell.2015.10.044